Financial Shenanigans

The Forensic Verdict

Target's reported numbers look like a faithful representation of economic reality. Operating cash flow has comfortably exceeded GAAP net income across the past decade, accruals are persistently negative (cash earned ahead of accrual profit), the audit opinion has been unqualified each year, the auditor flagged only one critical audit matter (vendor income receivable, $542M), and the FY2025 non-GAAP adjustment reduces Adjusted EPS below GAAP because management excluded a $593M interchange-fee gain that GAAP captured. The forensic risk score is 22 / 100 (Watch) — clean enough that accounting risk is a footnote, not a thesis driver, with two modestly elevated areas: (1) episodic working-capital lifts to CFO, most visible in FY2020 and FY2023, and (2) Ernst & Young's 95-year audit tenure. The data point that would change the grade is any sudden buildup in vendor income receivable, DPO, or supplier-finance balances paired with a CFO/NI ratio that drops below 1.0×.

13-Shenanigan Scorecard

Breeding Ground

Target's structural conditions for accounting strain are below average. The company runs a single US retail segment — no minority interests, no joint ventures of accounting consequence, no meaningful foreign-subsidiary translation noise, no controlling shareholder. Compensation is at-risk and metric-based; the FY2025 STIP paid below target on both Net Sales (96.5% of goal) and Incentive Operating Income (80.8%) — bonus arithmetic punished management for the year's miss rather than smoothing it. Two yellow flags: EY's audit tenure dates to 1931, and Brian Cornell ran the company from 2014 to early FY2025 before handing the seat to Mike Fiddelke (Cornell remains as Chair). Both increase the surface area for entrenched judgment, but neither is paired with red-flag behavior elsewhere in the filings.

The two yellow flags are structural rather than evidentiary. Long auditor tenure raises the prior probability of complacency, but EY surfaced a CAM on vendor income receivable in FY2025 — an active judgment area, not a rubber stamp. The CEO transition landed cleanly: no inflated transformation reserve, severance paid in cash within the same fiscal year, and impairments itemized.

Earnings Quality

Earnings look earned, not engineered. Operating cash flow has exceeded net income in every year since FY2009 in this dataset; the gap is structural D&A (~$3.0B in FY2025 against $5.1B operating income), not an accruals trick. The single non-trivial item this year is the $593M interchange-fee litigation gain booked inside SG&A and therefore inside GAAP operating income — a one-time plaintiff-side legal recovery that lifted reported operating income by 11.6% but is properly classified and properly excluded from Adjusted operating income. The auditor flagged vendor income receivable ($542M) as the one CAM; the balance has been essentially flat year-over-year ($543M FY24 → $542M FY25), which is the conservative outcome.

The FY2025 chart shows the only earnings-quality story that matters this year. GAAP operating income of $5.12B includes a $593M plaintiff-side credit-card-interchange-fee settlement gain in SG&A. Strip it out and adjusted operating income falls to $4.78B — a real 14.2% year-over-year decline, larger than the 8.1% GAAP decline. Management discloses both numbers, and Adjusted EPS at $7.57 is lower than GAAP EPS at $8.13. This is rare and worth crediting: the non-GAAP adjustment makes the company look worse, not better.

The accrual ratio is negative every year, meaning operating cash flow is consistently larger than net income — the opposite signature of a company that is propping up reported earnings with non-cash accruals. The FY2020 reading of −13.1% is the COVID-era working-capital tailwind. The FY2023 reading of −8.2% reflects a $1.6B inventory drawdown and tax timing, not improved underlying earnings power. Across FY2023–FY2025 the average accrual ratio is approximately −6.3%.

The FY2022 capex spike to $5.5B (versus $2.7B D&A) coincided with the post-COVID inventory build and supply-chain investments — capex / D&A ran at 2.05x. That ratio normalized to 0.97x in FY2024 and 1.19x in FY2025. There is no evidence that operating costs are being parked in PP&E: the lift in PP&E gross book value tracks the disclosed store/distribution-center investment program, and management guides FY2026 capex at "approximately $5 billion" with 30 new stores planned, consistent with the historical run rate.

Cash Flow Quality

Operating cash flow is durable but episodically flattered by working capital. The 3-year cumulative CFO/NI ratio is 1.89x and the 5-year is 1.62x — high, but consistent with the structural depreciation base of a 1,995-store fleet on owned real estate. The episodic flatter is visible in three places: (1) FY2020 CFO of $10.5B vs net income of $4.4B was driven by accounts payable expanding $2.94B and inventory plus other working-capital items contributing roughly $2B more on a COVID demand surge; (2) FY2023 CFO of $8.6B included a $1.6B inventory drawdown that reversed FY2022's pre-tariff overbuy; (3) FY2025 CFO of $6.6B is down from $7.4B because, per management's MD&A, "lower accounts payable leverage and inventory purchases" reduced the working-capital tailwind. That is the right framing — working capital is a real but cyclical CFO lever, and FY2025 is the year it began to give back.

The chart reveals the fingerprint of a normal retail working-capital cycle: 2020–2021 saw both inventory and payables expand sharply on COVID demand; 2022 saw both contract as Target unwound the inventory overhang; 2024 saw both rebuild; 2025 began to give back. There is no pattern of stretching payables to manufacture CFO. Days-payable-outstanding has been remarkably stable at 60–63 days for five years, and the cash-conversion-cycle has hovered between -3 and +0 days.

DPO peaked at 69 days in FY2021 and has retraced to 62 days. There is no creeping payable-stretching pattern. Supplier-finance program data, disclosed under ASU 2022-04, shows confirmed obligations declining from $3.67B at FYE 2024 to $3.03B at FYE 2025 — a $640M reduction. Companies that aggressively use supplier finance to flatter CFO show rising confirmed balances; Target's are shrinking.

Metric Hygiene

Target's KPI disclosures are reasonable, with one judgment call worth naming. Adjusted EPS, Adjusted Operating Income, and after-tax ROIC are the three reader-facing non-GAAP metrics; they were used internally as well, are reconciled in the 10-K, and the FY2025 Adjusted EPS of $7.57 is lower than GAAP at $8.13 — a conservative result driven by excluding the $593M interchange-fee gain. The same gain was also excluded from Incentive Operating Income for STIP purposes, alongside the $250M business-transformation cost; on a net basis this reduced incentive OI by $343M, making bonuses harder to earn. Comparable sales, traffic, ticket, channel mix, store counts, and segment revenue are disclosed consistently. The single judgment call is that GAAP operating income includes the $593M interchange gain — technically permitted, but readers who anchor on operating income without reading the MD&A footnotes will overstate the run-rate.

The asymmetry to watch is whether future non-GAAP and Incentive OI definitions continue to exclude both gains and losses. This year the $593M gain (excluded) was larger than the $250M cost (excluded), making the adjustment net-negative to bonus payouts. If a future year features a large one-time loss without an offsetting gain and the company excludes only the loss, the metric becomes promotional. That has not happened; it is the single thing to monitor on the metric-hygiene axis.

What to Underwrite Next

Five items are worth tracking. They are listed in priority order.

Accounting risk at Target is a footnote, not a thesis driver. The reported numbers can be taken at face value with two caveats: (1) GAAP operating income for FY2025 is flattered by $593M of one-time legal recovery and the run-rate is closer to the $4.78B Adjusted figure; (2) operating cash flow has been episodically helped by working-capital expansion in 2020–2021 and 2023, and FY2025 shows that lever turning back. Neither caveat changes the underwriting case materially. Position-sizing should reflect the demand weakness in comp sales and traffic, the earnings sensitivity to tariff resolution under the IEEPA SCOTUS ruling, and the new CEO's execution — not accounting concerns. Forensics supports a normal margin of safety, not a haircut.